Obesity has long been associated with encouraging the growth of tumor cells, but a recent study reveals that obesity can also play a role in improved outcomes in cancer patients treated with immunotherapy.
Researchers from around the nation will meet at the University of Oklahoma Health Sciences Center in early December to discuss the ways nanotechnology can be used to detect, diagnose and treat cancer.
Ian F. Dunn, M.D., has been named chairman and a professor of the Department of Neurosurgery at the University of Oklahoma College of Medicine. He will also hold the Harry Wilkins, M.D. Chair in Neurosurgery.
On November 10, 2018 the University of Oklahoma announced a $34 million dollar gift made to the Harold Hamm Diabetes Center (HHDC) at OU Medicine.